Al-Awadi M, Pavlik A, Al-Sarraf H
Department of Physiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat-13110, Kuwait.
Life Sci. 2006 Jul 24;79(9):847-53. doi: 10.1016/j.lfs.2006.02.039. Epub 2006 Apr 17.
The brain uptake and brain to blood efflux transport of (14)C-GABA were studied in spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto (WKY) rats using 20 min bilateral in situ brain perfusion in rats anesthetized using urethane. The volume of distribution (Vd) of (14)C-GABA into cerebrospinal fluid (CSF) and brain regions (cortex, diencephalon, cerebellum, and brain stem) was significantly greater in SHR than in the corresponding regions in WKY rats (p<0.05). The estimated Vd value of (14)C-GABA in CSF of SHR was 3.4 fold greater than that in WKY. Also compared to WKY, the Vd of (14)C-GABA into cerebellum and cortex of SHR was 15.3 fold and 19.4 fold greater, respectively. Although the study of blood-brain barrier (BBB) integrity using (3)H-mannitol revealed increased paracellular permeability at the brain capillaries of SHR when compared to WKY rats, this was found to be only partially responsible for the increased (14)C-GABA uptake. The study of brain to blood efflux transport of (14)C-GABA (after loading of brain with (14)C-GABA by vascular perfusion) revealed that the half-time of elimination was significantly shorter in SHR (5.35+/-0.66 min) than in WKY rats (14.83+/-1.94 min), (p<0.001). HPLC analysis revealed that GABA concentrations in brain extracts and CSF of SHR were similar to those in WKY rats (p>0.05). The faster efflux in SHR might be, at least partially, responsible to compensate for increased uptake of this neurotransmitter and to preserve the protective function of BBB towards GABA. The protective function of the BCSFB towards GABA appears to be also preserved, since systemic infusion of GABA within a wide range of administered doses (0.004-5.00 mg/kg) produced an increase in GABA CSF concentration from around 0.5 microM to only 11 microM, and the obtained pattern of CSF GABA concentrations under these conditions did not differ between SHR and WKY rats, as revealed by HPLC.
利用氨基甲酸乙酯麻醉大鼠,通过20分钟的双侧原位脑灌注,研究了(14)C - GABA在自发性高血压大鼠(SHR)和正常血压的Wistar Kyoto(WKY)大鼠中的脑摄取及脑 - 血外流转运情况。与WKY大鼠相应脑区相比,SHR中(14)C - GABA在脑脊液(CSF)和脑区(皮质、间脑、小脑和脑干)的分布容积(Vd)显著更大(p<0.05)。SHR脑脊液中(14)C - GABA的估计Vd值比WKY大鼠高3.4倍。与WKY相比,SHR中小脑和皮质中(14)C - GABA的Vd分别高15.3倍和19.4倍。尽管使用(3)H - 甘露醇研究血脑屏障(BBB)完整性发现,与WKY大鼠相比,SHR脑毛细血管的细胞旁通透性增加,但这仅部分解释了(14)C - GABA摄取增加的原因。对(14)C - GABA脑 - 血外流转运的研究(通过血管灌注使脑加载(14)C - GABA后)显示,SHR中消除半衰期(5.35±0.66分钟)显著短于WKY大鼠(14.83±1.94分钟),(p<0.001)。高效液相色谱分析显示,SHR脑提取物和脑脊液中的GABA浓度与WKY大鼠相似(p>0.05)。SHR中更快的外流转运可能至少部分负责补偿这种神经递质摄取的增加,并维持BBB对GABA的保护功能。血 - 脑脊液屏障(BCSFB)对GABA的保护功能似乎也得以保留,因为在广泛的给药剂量范围(0.004 - 5.00 mg/kg)内全身输注GABA,使脑脊液中GABA浓度仅从约0.5 microM增加到11 microM,高效液相色谱显示,在这些条件下获得的脑脊液GABA浓度模式在SHR和WKY大鼠之间没有差异。